SCHEMBL24690107

SCHEMBL24690107

COCCOc1ccc(CNC(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.66
▸ MAPK14 Q16539 2/20 0.65
▸ NPC1 O15118 6/20 0.65
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ HTT P42858 2/20 0.60
▸ MMP13 P45452 2/20 0.60
▸ MMP2 P08253 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ STAT3 P40763 1/20 0.60
▸ ALDH1A1 P00352 4/20 0.58
▸ MAPT P10636 3/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ EPHX2 P34913 2/20 0.56
▸ NR1H4 Q96RI1 2/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ MAPK1 P28482 1/20 0.55
▸ POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12215290 0.85 NPC1 (0.74) LMNAMAPK14NPC1SMN1; SMN2HTT
SCHEMBL29982783 0.84 TSHR (0.54) LMNASMN1; SMN2CYP3A4ALDH1A1MAPT
SCHEMBL13932522 0.83 ALDH1A1 (0.78) LMNAMAPK14SMN1; SMN2HTTMMP13
SCHEMBL24690189 0.81 MTNR1A (0.55) LMNASMN1; SMN2ALDH1A1MAPTRAB9A
SCHEMBL13947386 0.81 ALDH1A1 (0.66) LMNAMAPK14NPC1SMN1; SMN2HTT
SCHEMBL26601296 0.80 TSHR (0.50) LMNASMN1; SMN2CYP3A4ALDH1A1MAPT
SCHEMBL31061058 0.79 MAPK14 (1.00) LMNAMAPK14NPC1SMN1; SMN2HTT
SCHEMBL7990811 0.79 EPHX2 (0.67) LMNAMAPK14NPC1SMN1; SMN2ALDH1A1
SCHEMBL7986010 0.79 PRSS1 (0.63) LMNASMN1; SMN2EPHX2NR1H4
SCHEMBL9416606 0.79 NPC1 (0.82) MAPK14NPC1SMN1; SMN2ALDH1A1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224212-A1 GPR35 AGONIST COMPOUNDS HEPTARES THERAPEUTICS LIMITED (GB) 2022-10-27 — — WO disclosed
Send feedback